Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 41.3214.2638.52736.19-

What is the latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA is 41.32 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202441.32
Mar202314.26
Mar202238.52
Mar2021736.19
Mar2020-

How is Price to Cash Earnings (PCE) of ORCHID PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 41.32
189.76
Mar2023 14.26
-62.98
Mar2022 38.52
-94.77
Mar2021 736.19
0
Mar2020 0 -

Other Financial Ratios of ORCHID PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,930.8 Cr 9.9% -2.5% -28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

9.9%

-2.5%

-28.7%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses